300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Music
Wine and Spirits
Manufacturing
FinTech
Finance
Art
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Real Estate
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Sporting Goods
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Ecuador
Jersey
Bahrain
Bolivia
Belize
Algeria
Italy
Estonia
Belarus
Finland
Hungary
Bahamas
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Oxford University Innovation, VC Fund

Oxford University Innovation

VC Fund

Oxford, United Kingdom

Oxford University Innovation is a VC fund in Oxford focused on Software and Biotechnology. Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation alsomanages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics.Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.”Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Total investments:
68
Last investment:
Lead investor:
16%
Last fund:

Last updated:

Industries Oxford University Innovation invests in

SoftwareBiotechnologyHealth CareArtificial IntelligenceMedical

Stages Oxford University Innovation invests in

Funding RoundSeedSeries APre-SeedSeries B

Countries Oxford University Innovation invests in

United KingdomUnited StatesCanadaSwitzerlandThe Netherlands

Contacts

NameEmailPhoneSocials
Adam Stoten Adam Stoten
Gregg Bayes-Brown Gregg Bayes-Brown
Mairi Gibbs Mairi Gibbs
See all 6 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Software 21 (31%)
  • Biotechnology 16 (24%)
  • Health Care 13 (19%)
  • Artificial Intelligence 9 (13%)
  • Medical 8 (12%)
See all 105 industries →

Stage

  • Funding Round 25 (37%)
  • Seed 21 (31%)
  • Series A 9 (13%)
  • Pre-Seed 3 (4%)
  • Series B 3 (4%)
See all 8 stages →

Country

  • United Kingdom 55 (81%)
  • United States 3 (4%)
  • Canada 1 (1%)
  • Switzerland 1 (1%)
  • The Netherlands 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Adam Stoten
Adam Stoten Chief Operating Officer
Chief Operating Officer Total investments: 0
Find email
Gregg Bayes-Brown
Gregg Bayes-Brown Marketing and Communications Manager
Marketing and Communications Manager Total investments: 0
Find email
Mairi Gibbs
Mairi Gibbs Head of Operations
Head of Operations Total investments: 0
Find email
Ajoy Mallik
Ajoy Mallik Oxford Angels Network
Oxford Angels Network Total investments: 0
Find email
Essa Saulat
Essa Saulat Startup Mentor
Startup Mentor Total investments: 0
Find email
See all 6 team members →

Investments

CompanyDescriptionRoundLinks
MoA Technology MoA Technology
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems. $29.7M / Series C / Jul 23, 2026
Endlyz Therapeutics Endlyz Therapeutics
ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias. $17.3M / Seed / Apr 23, 2026
Scripta Therapeutics Scripta Therapeutics
Scripta Therapeutics operates as a bio-tech company, that delivers transformative therapeutics through cutting edge technology. $12M / Seed / Nov 13, 2025
DaltonTx DaltonTx
DaltonTx platform provides pharma, biotech, and CROs with the intelligence backbone that modern R&D and redefining how technology powers drug discovery. $5.4M / Seed / Sep 23, 2025
Palmer Energy Technology Palmer Energy Technology
Palmer Energy Technology offers advanced battery energy storage system technologies to secure customized, scalable, clean energy systems that reduce carbon emissions and enhance energy independence. $6.8M / Series A / Aug 28, 2025
Oria XR Oria XR
Oria XR is an innovative startup dedicated to revolutionizing medical training through the power of Virtual Reality (VR) and extended reality (XR) technologies. Our mission is to empower medical professionals and engineers with cutting-edge technology and unparalleled training experiences, ensuring they have the skills and confidence needed toexcel in their fields. At Oria XR, we believe in setting the gold standard in medical training and support. $12.9K / Pre-Seed / Jul 26, 2024
CryoLogyx CryoLogyx
CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery. Their exclusive technology is transforming cell freezing, storage, and transportation. Innovation ensures the delivery of viable cells and cell therapies in the appropriate format, ready to use whenever our customers require them. $636.3K / Seed / Mar 18, 2024
Caristo Diagnostics Caristo Diagnostics
Caristo Diagnostics is revolutionizing cardiovascular diagnostics and risk prediction with its advanced, AI-based CT imaging analysis tools. $16.3M / Series A / Apr 17, 2023
Brill Power Brill Power
Brill Power is a clean-tech platform that develops cutting-edge battery management technology to increase the lifetime performance of lithium-ion battery packs. Founded in 2016, the company is headquartered in Oxford, England. $10.5M / Series A / Jul 19, 2022
Brainomix Brainomix
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time. $21.3M / Series B / Dec 16, 2021
See all 68 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Music
Wine and Spirits
Manufacturing
FinTech
Finance
Art
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Real Estate
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Sporting Goods
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Ecuador
Jersey
Bahrain
Bolivia
Belize
Algeria
Italy
Estonia
Belarus
Finland
Hungary
Bahamas
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Oxford University Innovation invest in?

Oxford University Innovation invests primarily in Software, Biotechnology and Health Care startups, most often at Funding Round and Seed stage. Most of the 68 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Oxford University Innovation?

Public channels for Oxford University Innovation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Oxford University Innovation?

The team at Oxford University Innovation includes Adam Stoten (Chief Operating Officer), Gregg Bayes-Brown (Marketing and Communications Manager) and Mairi Gibbs (Head of Operations), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Oxford University Innovation Oxford University Innovation Find emails